Funds and ETFs Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Real-time Estimate Cboe Europe 05:34:41 2024-04-15 am EDT 5-day change 1st Jan Change
602.5 DKK +2.21% Intraday chart for Zealand Pharma A/S -7.72% +61.84%
Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
589.5 DKK
Average target price
754.3 DKK
Spread / Average Target
+27.95%
Consensus
  1. Stock Market
  2. Equities
  3. ZEAL Stock
  4. Funds and ETFs Zealand Pharma A/S